<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01544712</url>
  </required_header>
  <id_info>
    <org_study_id>Ref 2004/08 st 3</org_study_id>
    <nct_id>NCT01544712</nct_id>
  </id_info>
  <brief_title>Controlled Study of Stage 3 Osteonecrosis Treatment by Bone Marrow</brief_title>
  <official_title>Treatment of Stage 3 Osteonecrosis of the Femoral Head by Autologous Transplantation of Bone Marrow Cells: a Randomized, Controlled Double Blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of Liege</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital of Liege</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In stage 3 Osteonecrosis (ON) of the femoral head, a beneficial effect of bone marrow
      grafting was reported with a reduction of the functional evolution and the necessity of a
      total prosthesis placement in a non-controlled retrospective trial. Based on this experience,
      the investigators would like to start a randomized controlled double blind study on the
      effect of autologous implantation of autologous bone marrow cells into the necrotic lesion of
      stage 3 ON of the femoral head.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2004</start_date>
  <completion_date type="Actual">September 2010</completion_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>reduction of total prosthesis</measure>
    <time_frame>24, 60 months</time_frame>
    <description>Need to undergo a surgical treatment total prosthesis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain reduction</measure>
    <time_frame>24, 60 months</time_frame>
    <description>Visual analogue scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>functional status</measure>
    <time_frame>24, 60 months</time_frame>
    <description>Lequesne and WOMAC scores</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Non Traumatic Osteonecrosis of the Femoral Head (Hip)</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Core decompression</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bone marrow</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>core decompression plus autologous concentrated bone marrow</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>core decompression with autologous bone marrow implantation</intervention_name>
    <description>core biopsy with injection of 40 ml concentrated autologous bone marrow.</description>
    <arm_group_label>Bone marrow</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>core decompression of the femoral head</intervention_name>
    <description>core biopsy with injection of 40 ml saline solution in place of bone marrow.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. patients who have a non traumatic ON of the femoral head

          2. Stage 3 ON (subchondral fracture).

          3. Age &gt; 18 years

          4. Be able and willing to participate in the study

        Exclusion Criteria:

          1. evidence of malignant disorder in the past five years

          2. Patient unable to undergo a MRI.

          3. Patient who is positive for an HIV, hepatitis B or C infection.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Liège</name>
      <address>
        <city>Liège</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2012</study_first_submitted>
  <study_first_submitted_qc>March 5, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 6, 2012</study_first_posted>
  <last_update_submitted>March 5, 2012</last_update_submitted>
  <last_update_submitted_qc>March 5, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 6, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital of Liege</investigator_affiliation>
    <investigator_full_name>Jean-Philippe Hauzeur</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>osteonecrosis</keyword>
  <keyword>cell-based therapy</keyword>
  <keyword>bone marrow</keyword>
  <keyword>mesenchymal stem cell</keyword>
  <keyword>hip</keyword>
  <keyword>core decompression</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteonecrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

